HepBaware

GSK 희망 알림 BC

Face the Day

MyAsthma UK

Piri Pollen

NO MAS COBRAS

Children's Panadol

MyAsthma Canada

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

Apple Mobile Web Clips Icon

Euro

Google Font API

HSTS

Content Delivery Network

Font Awesome

Principal Stat Prog

Abhay Kumar

SVP, Chief Technology Officer

Agam Upadhyay

Business System Owner and System Support Specialist

Allen Shatley

Business Process Anaylist / Service Owner

Ben Holladay

QA Systems Specialist- Change Control Process Owner

Carly Smith

Assistant General Counsel

Charn Reid

Principal Scientist-Qabsss (Secondment)

Chasidy Cockman

Demand Planning Global Process Owner

Chip Autry

President, Americas Region, Consumer Healthcare

Chris Slager

Data Communications Manager - Global Communications & CEO Office

Colleen Bezich

Simon Dingemans

Philip Hampton

Sharon O Kane

Stacey Cartwright

Moncef Slaoui

Daniel Podolsky

Lynn Elsenhans

Vindi Banga

Emma Walmsley

Brian McNamara

CEO GSK Consumer Healthcare

Roger Connor

President, Global Vaccines

Olivier Le Bussy

R&D Scientist

Pascal Ducheix

Digital Media Procurement Director

Katrin Haram

Sales and Marketing Coordinator

Mark G. Miller

Team Member

Love Oyeniran

RPA Tech Security and Risk Consultant

23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.

Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

London Public Companies With More Than $500 in Revenue

Investors Active in West Coast (Top 10K)

Biotechnology Companies With More Than 1000 Employees

Biotechnology Companies With More Than $1B in Revenue

GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

The company aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with its 3 global businesses, scientific and technical know-how, and talented people. 

GSK's Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, the use of genetics, and advanced technologies.

The Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. It delivers over two million vaccine doses per day to people living in over 160 countries.

The Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert-recommended brands in the Pain relief, Respiratory, Digestive health, Oral Health, Nutrition, and Skin health categories.

CARB-X

Grant - GlaxoSmithKline

London

England

United Kingdom

Europe

GlaxoSmithKline

GSK boosts profit forecast after strong sales in cancer and HIV treatments

GSK raises annual profit and sales forecast after second quarter beat

GlaxoSmithKline posts rising sales but shares slide amid fears over vaccines division

GlaxoSmithKline Pharma Q4 net profit grows 46% to Rs 194.5 crore, declares Rs 32/share dividend

GSK raises profit guidance as vaccine demand grows

GSK raises profit outlook on strong vaccine, HIV drug sales

United States

North America

Canada

Poland

Japan

Asia

HTML5

jQuery

Google Fonts

GlobalSign

Google Tag Manager

Bootstrap

Office 365

Comodo PositiveSSL Certificates

Microsoft Outlook

Google Doubleclick

GlaxoSmithKline owns SR One

GlaxoSmithKline owns GSK - Cephalosporins Antibiotics Business

GlaxoSmithKline owns GSK

GlaxoSmithKline owns GlaxoWellcome

GlaxoSmithKline owns GlaxoSmithKline Consumer Healthcare (GSK CH India)

GlaxoSmithKline owns Glaxo Saudi Arabia Ltd

GlaxoSmithKline owns Glaxo Group

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

news impact assignment basic	general	Mar 8, 2024 1:57 PM	2ebe1906
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 1:57 PM	b64661fe
company summary	general
signals	general
crunchbase trigger	general	Oct 29, 2024 5:10 PM	655db202
crunchbase profile	general	Oct 29, 2024 5:30 PM	a6149add
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	76fbdf78
peers	general
news basic	general	Mar 8, 2024 1:57 PM	8c9e4978
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:GSK

GSK plc

Last Close

1,342.00

25/11 09:24

Market Cap

617.02M

Beta: -

Volume Today

577.46K

Avg: -